Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19452540

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2009 Jul 1
First author
Berger M

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2009 Nov 1;115(21):5126
    note
    Massimo, Berger [corrected to Berger, M]; Giovanni, Grignani [corrected to Grignani, G]; Stefano, Ferrari [corrected to Ferrari, S]; Eleonora, Biasin [corrected to Biasin, E]; Adalberto, Brach Del Prever [corrected to Brach del Prever, A]; Sandra, Aliberti
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null

Authors and identifiers

  1. name
    Berger M
    type
    Author
  2. name
    Grignani G
    type
    Author
  3. name
    Ferrari S
    type
    Author
  4. name
    Biasin E
    type
    Author
  5. name
    Brach del Prever A
    type
    Author
  6. name
    Aliberti S
    type
    Author
  7. name
    Saglio F
    type
    Author
  8. name
    Aglietta M
    type
    Author
  9. name
    Fagioli F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Berger M
    type
    Author
  2. name
    Grignani G
    type
    Author
  3. name
    Ferrari S
    type
    Author
  4. name
    Biasin E
    type
    Author
  5. name
    Brach del Prever A
    type
    Author
  6. name
    Aliberti S
    type
    Author
  7. name
    Saglio F
    type
    Author
  8. name
    Aglietta M
    type
    Author
  9. name
    Fagioli F
    type
    Author
bibliography ids
  1. nci-bib-e29ebce1ab790caab5642ad8
book metadata
content sha256
d62842a4a54b9ecc680aad09768d6d2d7a6a96b5311447448b7fb0899b1a5461
document type
citation
dois
  1. 10.1002/cncr.24368
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:19452540
immutable id
pubmed:19452540@d62842a4a54b9ecc680aad09768d6d2d7a6a96b5311447448b7fb0899b1a5461
journal
abbreviation
Cancer
issn electronic
Source null
issn print
0008-543X
issue
13
name
Cancer
nlm unique id
0374236
pages
2980-7
volume
115
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2009 Nov 1;115(21):5126
    note
    Massimo, Berger [corrected to Berger, M]; Giovanni, Grignani [corrected to Grignani, G]; Stefano, Ferrari [corrected to Ferrari, S]; Eleonora, Biasin [corrected to Biasin, E]; Adalberto, Brach Del Prever [corrected to Brach del Prever, A]; Sandra, Aliberti
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
outcomes validated
false
pmid
19452540
provenance
batch id
4f803f1a8e7b4f56d2f1
provider
NCBI PubMed ESummary
record sha256
dee28c9ddfb749cf7e53f9ee8c8f5e19b453e29866bf66d7dc4905fec3c7b974
response sha256
fddd7745d591ed24e15d20ce21f0a6c14874b8cee29153ff89c9892037c40127
retrieved at
2026-09-09T23:46:26.391289+00:00
publication date
display
2009 Jul 1
precision
day
year
2009
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19452540/
title
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.

Preserved source evidence · Not medical advice